Medication info
Dainab Tablet (Metformin Hydrochloride)

Dainab Tablet (Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
HuTechs Pharma Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Active

MFDS item code 201400772 · Approved 2014.02.20 · Insurance code 649102270

Summary

Main use
Treatment of type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Adults The dose should be determined individually based on efficacy and tolerability and must not exceed the recommended maximum daily dose. This medicine must be started at a low dose to reduce gastrointestinal adverse reactions and identify the minimum dose needed for adequate glycemic control. Take 500mg per dose 2-3 times daily with meals. Increase the dose gradually by 500mg each week; when taking up to 2000mg, the dose is usually divided into 2 doses daily, taken in the morning and evening. For doses above 2000mg, divide the daily dose into 3 doses taken with meals; the maximum daily dose is 2550mg. At treatment initiation and when adjusting the dose, measure fasting blood glucose to assess response to treatment with this medicine and identify the minimum effective dose. Measure blood hemoglobin A1c approximately every 3 months. The goal of treatment with this medicine, whether used as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood hemoglobin A1c to normal or near-normal levels using the minimum effective dose. In general, if a patient whose blood glucose was controlled by diet alone experiences temporary loss of glycemic control, short-term treatment with this medicine may be sufficient to achieve an adequate effect. Patients with renal impairment This medicine may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who have no other condition that may increase the risk of lactic acidosis, with the following dose adjustment: - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, this medicine must be discontinued immediately.
Child dose
Children and adolescents who are 10 years of age or older: The usual starting dose is 500 milligrams once daily, administered during or after a meal. Measure blood glucose after one week and adjust the dose. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. Divide this dose into 2~3 doses.

Ingredients

Manufacturer
HuTechs Pharma Co., Ltd.

Efficacy & effects

Treatment of type 2 diabetes mellitus

  • Abnormal blood sugar control in patients with type 2 diabetes
  • overweight
View approved original text

This medication is used for the treatment of patients with type 2 diabetes whose blood sugar control is insufficient with diet and exercise. It is particularly effective for overweight diabetic patients. It can be used alone or in combination with other oral hypoglycemic agents or insulin in adult patients. Additionally, it can be used for children over 10 years old and adolescents in growth, either alone or in combination with insulin. This medication helps effectively manage blood sugar and maintain a healthy blood sugar level.

How to take

Adult dose

Adults The dose should be determined individually based on efficacy and tolerability and must not exceed the recommended maximum daily dose. This medicine must be started at a low dose to reduce gastrointestinal adverse reactions and identify the minimum dose needed for adequate glycemic control. Take 500mg per dose 2-3 times daily with meals. Increase the dose gradually by 500mg each week; when taking up to 2000mg, the dose is usually divided into 2 doses daily, taken in the morning and evening. For doses above 2000mg, divide the daily dose into 3 doses taken with meals; the maximum daily dose is 2550mg. At treatment initiation and when adjusting the dose, measure fasting blood glucose to assess response to treatment with this medicine and identify the minimum effective dose. Measure blood hemoglobin A1c approximately every 3 months. The goal of treatment with this medicine, whether used as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood hemoglobin A1c to normal or near-normal levels using the minimum effective dose. In general, if a patient whose blood glucose was controlled by diet alone experiences temporary loss of glycemic control, short-term treatment with this medicine may be sufficient to achieve an adequate effect. Patients with renal impairment This medicine may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who have no other condition that may increase the risk of lactic acidosis, with the following dose adjustment: - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, this medicine must be discontinued immediately.

Child dose

Children and adolescents who are 10 years of age or older: The usual starting dose is 500 milligrams once daily, administered during or after a meal. Measure blood glucose after one week and adjust the dose. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. Divide this dose into 2~3 doses.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia, so caution is required. It should particularly not be administered to patients with moderate to severe kidney dysfunction, or acute conditions such as dehydration, severe infections, or acute myocardial infarction. Patients with acute and unstable heart failure, those undergoing examinations with radiographic iodine contrast agents, and patients with hypersensitivity to this medication or other biguanides should also avoid use. It should not be used in patients with type 1 diabetes or metabolic acidosis, and patients with severe infections or traumatic systemic disorders, as well as those before and after surgery should temporarily discontinue use. Caution is also necessary for patients with malnutrition, liver dysfunction, pulmonary dysfunction, and excessive alcohol consumption. During the administration of this medication, kidney function should be regularly monitored to prevent drug accumulation. Gastrointestinal symptoms may commonly occur during initial treatment, but they are usually temporary and can be alleviated by taking the medication with meals or gradually increasing the dosage. Symptoms of lactic acidosis include fatigue, muscle pain, shortness of breath, and abdominal pain, so if these symptoms occur, the patient should immediately inform their physician. Alcohol consumption should be avoided during the use of this medication, and if combined with other hypoglycemic agents, the risk of hypoglycemia may increase, thus careful monitoring of blood sugar is required. The decision to administer during pregnancy should take into account the potential effects on the fetus and placental function, and during breastfeeding, the decision regarding whether to continue breastfeeding or discontinue the medication should be made carefully as this medication is secreted into breast milk. Elderly or pediatric patients should have their kidney function and growth status monitored closely and the dosage adjusted accordingly. In case of overdose, the drug can be removed via hemodialysis, so if overdose is suspected, immediate consultation with medical personnel is necessary. This medication does not cause weight gain, making it favorable for weight management, and long-term use can help with blood sugar control and the prevention of diabetic complications. Store out of reach of children and do not transfer to another container for safety.

Side effects

  • Lactic acidosis
  • diarrhea
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • dyspepsia
  • constipation
  • abdominal pain
  • metallic taste
Show 7 more
  • rash
  • anemia
  • leukopenia
  • thrombocytopenia
  • vitamin B12 deficiency
  • liver function abnormalities
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air exposure, at room temperature between 1 to 30 degrees Celsius. This storage method helps maintain the medication's effectiveness and prevents degradation.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.